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Immunosenescence is described as a decline in the normal functioning of the immune system associated with physiologic age-
ing. Immunosenescence contributes to reduced efficacy to vaccination and increased susceptibility to infectious diseases in the 
elderly. Extensive studies of laboratory animal models of ageing or donor lymphocyte analysis have identified changes in im-
munity caused by the ageing process. Most of these studies have identified phenotypic and functional changes in innate and 
adaptive immunity. However, it is unclear which of these defects are critical for impaired immune defense against infection. 
This review describes the changes that occur in innate and adaptive immunity with ageing and some age-related viral diseases 
where defects in a key component of immunity contribute to the high mortality rate in mouse models of ageing. 
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1  Ageing and immunosenescence 
The human lifespan has significantly increased in the de-
veloped world over past decades because of socioeconomic 
development and medical care improvement. The global 
population is ageing and the proportion of elderly individu-
als aged 60 years and older is expected to reach 21% of the 
whole population by 2050 [1]. This presents a major chal-
lenge to public health services as the elderly are a vulnera-
ble population to emerging infectious diseases, such as 
pandemic influenza (H5N1), West Nile virus (WNV) and 
severe acute respiratory syndrome (SARS) [24]. Moreover, 
immunosenescence renders vaccination less effective in the 
elderly. For example, the yearly influenza vaccine is only 
29%–46% efficacious in persons aged 75 years and 
41%–58% in persons 60–74 years old [5] compared to 
70%–90% in young adults [4]. Additionally, reduced im-
mune responses have been observed in elderly individuals 
vaccinated against tetanus, hepatitis and Streptococcus 
pneumonia [2]. Thus, there is an urgent need to develop 
strategies for improving vaccination efficacy and therapies 
to strengthen immunity in the elderly. However, to achieve 
this goal, a thorough understanding of the mechanisms un-
derlying the age-related decline in immunity is needed.  
2  Ageing and the adaptive immune system 
Adaptive immunity includes B and T lymphocytes that re-
spond to challenges with a high degree of specificity and 
memory. The competency of the adaptive immune function 
decreases with age. Both T cell mediated cellular immunity 
and B cell mediated humoral immunity are involved in im-
munosenescence. 
2.1  Effect of ageing on T cell immunity  
The age-related decline in T cell immunity is mainly char-
acterized by a decrease in numbers of naïve T cells [6,7] 
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and the expansion of memory T cells, especially late-stage 
differentiated CD8+ cells. These result in reduced T cell 
TCR diversity and function [8–10]. Another feature of the T 
cell compartment in ageing humans or mice is the accumu-
lation of large oligoclonal expansions of CD8+ T cells that are 
often cytomegalovirus (CMV)-specific [11–13]. Through 
longitudinal studies, Pawelec et al. [14] found that CMV 
seropositivity has a direct relation to immune risk pheno-
type (IRP). The IRP is characterized by decreasing naïve 
CD4+ cell numbers, an inverted ratio of CD4/CD8 cells and 
CD8+ T cell repertoire (TCR) disturbance [15–17]. About 
60%–100% of the human population is persistently or la-
tently infected with CMV, and chronic infection by CMV 
may accelerate ageing of the immune system and lead to a 
high levels of chronic subclinical inflammation [18]. CMV-      
specific CD8+ T cell expansion, resulting in a decrease of 
peripheral naïve CD8+ T cells and TCR diversity contrac-
tion, causes weak responses to new infectious pathogens 
[15,16]. Whether other viruses, such as Epstein-Barr virus 
(EBV), herpesviruses (human herpesvirus, HHV) or poly-
omaviruses (BK virus, JC virus) may also contribute to ac-
celerated immunosenescence in the aged population is still 
not fully understood [19–21]. 
Another factor that contributes to immunosenescence of 
the T cell compartment is age-associated thymic involution. 
The decline in thymus function causes a dramatic decrease 
in naïve T cell production in aged individuals [22,23]. This 
may be a good interpretation for immunosenescence, how-
ever, it cannot explain the fact that the total number of T 
lymphocytes is maintained quite well by homeostasis in 
healthy people [24,25]. Functional and phenotypic analysis 
indicated that other factors probably influence the process 
of age-related immunosenescence. Persistent or latent virus 
infection or other environmental factors may be “boosting 
elements”, but further studies are needed to investigate the 
impact of environmental factors on the ageing process.  
2.2  Effect of ageing on B cell mediated humoral im-
munity 
Age-associated immune dysfunction also occurs in B cell 
compartments, which results in impaired humoral immune 
functions [26,27]. However, both naïve and memory B cells 
are decreased with ageing [28,29], in contrast with the T 
cell compartments. Although the percentage and number of 
human B cell precursors in the bone marrow do not decline 
significantly during ageing [30], the total level of mature 
human B cells in peripheral blood significantly decreases 
with age [31–33]. Like T cell compartments, antigen-      
experienced memory cells are most prevalent in the periph-
eral B cell pool, resulting in limited B cell clonal expansion 
and repertoire diversity limitation [34,35]. Based on different 
antibody isotypes, human memory B cells can be subdivided 
into two distinct types: IgM memory (IgGIgACD27+) and 
switch memory (IgG+IgA+) B cells [36]. The absolute num-
ber of IgM memory B cells significantly decreases as a re-
sult of the decline of total B cell numbers. However, the 
percentage remains unchanged. However, the percentage 
and number of switch memory B cells decreases during 
ageing [37]. Functional analysis studies have demonstrated 
that both IgM memory B cells and switch memory B cells 
are impaired in the elderly, which helps to explain why vac-
cines have poor effects against infections in aged people 
[31,38]. Above all, antibodies secreted from B cells are also 
influenced by ageing. Johnson et al. [39] demonstrated that 
antibody affinity in aged individuals is lower than in young 
people, which also contributes to reduced protection from 
vaccination. 
Both humoral and cellular immune systems are affected 
in the ageing process, and most importantly, they are influ-
enced reciprocally. As an integral component of the im-
mune system, lymph nodes are the terminal point for col-
lecting antigens from peripheral tissues and recruiting naïve 
lymphocytes from the blood, providing the microenviron-
ment for primary and secondary immune responses. There-
fore, the lymph node is the perfect place for studying T cell 
and B cell interactions. Lazuardi and colleagues demon-
strated that interactions between T and B cells was impaired 
in aged people, leading to reduced B cell expansion and 
differentiation in response to antigens [40]. 
3  Ageing and innate immunity 
The innate immune system includes a diverse group of cell 
types including neutrophils, natural killer cells (NK), natu-
ral killer T cells (NKT), monocytes/macrophages and den-
dritic cells (DCs). The innate immune system, which serves 
as an immunological sentinel defense against microbial 
pathogens, is also affected at multiple levels during the 
ageing process [41,42], but the effects and mechanisms re-
main incompletely understood, particularly in humans. Here 
we discuss the recent findings in age-associated changes in 
NK cells. 
NK cells are an important component in innate immunity, 
play a critical role in host defense against invading patho-
gens and malignant transformation through rapid cytolytic 
activity or direct production of cytokines, such as interferon 
(IFN)- and tumor necrosis factor (TNF)- [43,44]. NK 
cells are derived from bone marrow. In humans, NK cells 
comprise about 15% of all blood lymphocytes and are de-
fined phenotypically by their expression of CD56 surface 
antigen and lack of expression of CD3 [43,45]. According 
to the cell surface density of CD56 and CD16 expression 
(FcγRIII), human NK cells can be divided into two distinct 
subsets, the majority (~90% in blood) of human NK cells 
are CD56dimCD16+, and a minor population (~10% in blood) 
is CD56bright CD16 [45]. Early functional studies revealed 
that CD56bright cells have the ability to produce abundant 
cytokines and have a high cytotoxic function, whereas 
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CD56dim cells may function as efficient effectors of natural 
and antibody-dependent target cell lysis [46,47]. However, 
when resting NK cells were activated with interleukin 
(IL)-2 or IL-12 in vitro, CD56bright and CD56dim cells exhib-
ited similar levels of cytotoxic ability [48,49]. 
NK cell immune functions and cellular phenotype are 
also influenced during ageing. Age-related changes in NK 
cell functionality are controversial. Previous studies focused 
on the cytotoxicity and numbers of NK cells in elderly peo-
ple have reported different and contradictory conclusions. 
Recent studies have demonstrated that the number of NK 
cells is stable or increases during ageing [50–54]. In addi-
tion, the NK subpopulations are also dynamically changed 
during ageing. The absolute number of CD56bright CD16 
cells declines with age and is associated with an increase in 
the CD56dimCD16+ population (highly mature cytotoxic 
subpopulation) [55]. This change results in increased NK 
cytotoxicity in elderly individuals, but from a per-cell based 
activity analysis, cytotoxic activation decreases with age 
[55–58]. The mechanisms of NK cell cytotoxic defects re-
main unknown.  
Mature NK cells normally remain quiescent until virus 
infection or other stress. They then rapidly proliferate ini-
tially in a nonspecific mode. The cytotoxicity of activated 
NK cells is regulated by the balance of signals from their 
own activating and inhibitory receptors [59]. To date, three 
receptor families have been characterized, including killer 
cell immunoglobulin-like receptors (KIRs), natural cyto-
toxicity receptors (NCRs), and C-type lectins [59–61]. Re-
cent studies have begun to elucidate age-associated changes 
of NK cell receptors. Lutz et al. demonstrated that the ex-
pression of KIRs is increased in the elderly population and 
this phenomenon is also observed in T-cell related receptor 
expression [6264]. In contrast, Almeida-Oliveira found no 
age-related changes in overall KIR expression on NK cells, 
but demonstrated an increase in KIR expression in the 
CD56bright subset of elderly subjects instead [65]. Their re-
sults are similar to a previous report [66]. Moreover, they 
also found the expression of C-type lectin CD94 and acti-
vating NCRs (NKp30, NKp46) decreased significantly in 
older adults compared to younger adults [65].  
Once activated, NK cells exhibit direct cytolytic activity 
on infected cells and release pro-inflammatory cytokines 
and chemokines that contribute to the adaptive Th1 immune 
response [67]. Some limited studies have focused on the 
effect ageing has on the production of cytokines and the 
regulatory role of NK cells on adaptive immunity. Previous 
studies indicated that cytokines and chemokines produced 
by NK cells in rodents decreased with advancing age. It was 
observed that IL-2-induced IFN- production and IL-2- or 
IL-12-induced production of chemokines such as macro-
phage inflammatory protein 1a (MIP-1a) and IL-8 were 
decreased in NK cells from aged individuals [68,69]. Moc-
chegiani et al. [70] showed that NK cell production of IFN-, 
TNF-, IL-2 and IL-12 was decreased in elderly individuals 
and might contribute to T cell deficits associated with age-
ing. However, in a recent study, IFN- production upon NK 
cell activation was shown to be significantly higher in the 
aged, particularly in subjects older than 85 years of age 
compared to younger adults [71]. Moreover, they found 
IFN--expressing NK cells correlated positively with the 
serum content of the –SH groups in seniors. Their findings 
indicated that activation of NK cells at an advanced age 
might be related to the oxidative and inflammatory status of 
the elderly.  
Many factors may influence the different results in these 
studies regarding NK cell activity, including (i) the criteria 
of selected subjects (age, sex, race, etc.); (ii) the subjects’ 
basic health and nutrition status; (iii) potential infection to 
virus or other pathogens; and (iv) chronic inflammation. At 
present, there is no standard criterion of senescence and it 
seems to vary with the development of the economy and 
subjects’ physical quality. Some studies indicated that NK 
cell activity and cytotoxicity could be modulated by exter-
nal agents such as zinc [70,72]. Recently, “inflamm-ageing” 
has been described, where healthy ageing individuals have 
an active inflammatory state, with high levels of IL-6, IL-1 
and tumor necrosis factor- (TNF-) [73]. Whether the 
elevation of these cytokines can regulate NK cell activity 
remains unknown. Clearly, we are still at the beginning of 
understanding the complicated changes in NK cell functions 
with ageing and further studies are needed to identify the 
mechanisms underlying these changes.  
4  Specific defects in the immune system and 
age-related viral diseases  
Although the defects in both the innate and adaptive im-
mune system contribute to immunosenescence, studies have 
also shown that it is significantly heterogeneous in individ-
uals. Moreover, the primary immune response is also dif-
ferent in the same individuals when infected with different 
pathogens. Experimental mice models have provided a good 
research platform to study age-related susceptibility to cer-
tain infectious diseases.  
4.1  T cell defects and West Nile virus infection 
West Nile virus (WNV) is the main cause of encephalitis in 
the West Nile region. The natural reservoirs for WNV are 
mosquitoes and birds, but it can also infect humans and 
other mammals [74]. There have been outbreaks and pan-
demics in North America and Africa and other countries in 
recent years [75,76]. The mortality rate in the infected pop-
ulation is about 10%. WNV disease is an age-related disease. 
The prevalence and mortality gradually increase during 
ageing, and the median age of death caused by WNV is 78 
years [77]. There is no protective vaccine or efficient anti-      
viral treatment available for WNV infection. Studies have 
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indicated that the innate immune system and T/B-cell medi-
ated immunity are involved in the control of WNV infection. 
B cell-deficient mice develop high viral titers in the blood 
[78]. However, T cell-mediated immunity seems to play a 
dominant role in the control of WNV infection. T-cell de-
fects significantly increase the lethality of WNV infection, 
and the survivors take many years to fully recover physical, 
functional and cognitive ability [79,80] .  
Using an aged mouse model, Brien et al. [81] showed 
that defects in T cells play a key role in age-related vulnera-
bility to WNV infection. Aged mice infected with WNV 
had a high mortality rate due to uncontrolled virus spread to 
the brain because of CD8 and CD4 T-cell functional defects. 
T cell responses in aged mice following WNV infection 
were weak demonstrated by insufficient numbers of ineffec-
tive effector T cells accumulating in the brains of WNV-    
infected old mice. Both CD4 and CD8 T cells exhibited 
profound quantitative and qualitative defects, but these de-
fects did not extend to all aspects of antigen recognition and 
activation. Furthermore, it seems that the ability of T cells 
to migrate into the mouse brain was not diminished, but that 
the infiltrating T cells had a diminished effector function 
[81]. Adoptive transfer of adult CD4 or CD8 T cells signif-
icantly protected aged mice against lethal WNV infection. 
Collectively, specific age-related defects in T cell immunity, 
affecting both CD8 and CD4 T cells, are the main reason for 
the increased susceptibility to WNV infection in the mouse 
model of ageing.  
4.2  NK cells defects and the mousepox model 
Mousepox is a viral disease caused by a specific mouse or-
thopoxvirus (OPV), called ectromelia virus (ECTV). ECTV 
is genetically very similar to the human pathogen variola 
virus (the agent of smallpox), and monkeypox virus (the 
agent of monkeypox). Monkeypox is a serious endemic 
disease in central Africa and a recent outbreak occurred in 
the USA [82,83]. Although all mouse strains can be infected 
with ECTV, the outcome of the infection following footpad 
inoculation varies. Some sensitive strains such as BALB/c 
develop mousepox and endure a very high mortality rate 
during the first two weeks post-infection (PI) [84,85], while 
other strains such as C57BL/6 (B6) control the infection 
without visible symptoms. The resistance of B6 mice to 
disease is not due to an inherent decreased ability of the 
virus to replicate in this strain but to the combined action of 
the innate and adaptive immune systems. Deficiencies in 
innate immune components caused by NK cell or macro-
phage depletion, or deficiencies in adaptive immune com-
ponents such as in CD8 T cell knockout mice, B cell 
knockout mice or severely immunodeficient (recombinase 
activating gene 1 knockout mice) mice in resistant B6 
background, all readily succumb to mousepox [86–90]. 
NK cells play an important role in controlling primary 
mousepox. Recently, we identified the mechanisms of NK 
cell mediated resistance to mousepox. After footpad ECTV 
infection, NK cells are activated and migrate to the local 
draining lymph nodes (D-LN), controlling early virus dis-
semination to the central organs by direct cytolytic function 
and by secreting anti-viral cytokines. NK cells responses 
also augment antiviral T cell responses [87]. Moreover, we 
also showed that NK cell activating receptor CD94-NKG2E 
can specifically recognize ECTV-infected cells, and another 
NK cell activating receptor NKG2D functions as a costim-
ulator [91].  
We observed that B6 mice gradually lose their natural 
resistance to mousepox as they age, and that resistance 
starts to wane at a relatively early age (~6 months) and is 
completely lost when mice reach 14 months of age. Sur-
prisingly, the main reason for the loss of resistance is not 
because of intrinsically defective T cell responses. Instead, 
the primary reason is because of defects in NK cell re-
sponses in the aged mice. We observed a decrease in the 
number of total and mature NK cells in the blood of aged 
mice [92]. In addition, after ECTV infection, mature NK 
cells in aged mice have an intrinsic defect in migration to 
the D-LN to prevent systemic virus spread. In our previous 
work, we demonstrated that D-LN is a major site for the 
prevention of viral spread [93]. Furthermore, lymph nodes 
are an important site for the initiation of immune responses, 
and where NK cells interact with other immune cells such 
as DCs and T cells, to regulate adaptive immune functions 
[94]. Therefore, our results demonstrate that NK cells from 
aged mice have defects in their ability to migrate to the 
D-LN after ECTV infection, which results in increased ear-
ly virus replication and spread as well as susceptibility to an 
acute viral disease. A model of this is shown in Figure 1. 
In contrast to the T cell defects observed in age-     
dependent susceptibility to WNV infection, NK cell defects 
directly result in the age-related susceptibility to mousepox. 
However, in both models, T cells and NK cells show im-
paired qualitative and quantitative functions. In the WNV 
model, the ability of T cells to migrate to the brain seems 
not to be defective; whereas in the mousepox model, mature 
NK cells have intrinsic defects in their migration to D-LNs. 
We further show that decreased CD62L expression on ma-
ture NK cells from aged mice might contribute to impaired 
migration. However, in both cases, the mechanisms under-
lying the functional defects are unknown. A comparison of 
the two models is summarized in Table 1.  
5  Conclusion 
Clearly, immunosenescence affects both innate and adaptive 
immunity. The key components of the ageing immune sys-
tems for protection against infectious diseases may vary as a 
result of different viruses, the infection route and dose. Alt- 
hough significant progress has been made in recent years, 
results from different experimental models and different  
 Ma Y C, et al.   Sci China Life Sci   May (2013) Vol.56 No.5 403 
 
Figure 1  Impaired NK cell responses result in a high mortality rate in aged mice upon ECTV infection. Following Ectromelia virus (ECTV) infection in 
young mice, natural killer (NK) cells, probably activated by cytokines, migrate to the D-LN and kill ECTV-infected cells via CD94-NKG2E that specifically 
recognize infected targets and NKG2D that acts as a costimulator. After ECTV infection in aged mice, NK cells fail to migrate to the D-LN to prevent early 
virus dissemination, which directly causes the death of aged mice.  
Table 1  Comparisons between aged-related susceptibility to WNV and 
ECTV infectiona) 
Model West Nile virus Ectromelia virus 
Immune system 
defects 







Migration ability Normal Defect 
Cause of death Meningoencephalitis Liver necrosis 
a) WNV, West Nile virus; ECTV, Ectromelia virus; NK, natural killer 
cells. 
 
subjects are not always consistent, and can show opposing 
results. Understanding how and why immune responsive-
ness changes in humans as they age is essential for devel-
oping strategies to prevent or restore impaired immunity 
and assure healthy longevity. We are still at the beginning 
of unraveling the mystery of immunosenescence. The 
knowledge we gain from further in depth studies will pave 
the way for rational interventions to maintain or restore ap-
propriate immune function in the elderly. 
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